The Latest: BioNTech to make vaccines in Singapore
BERLIN – German pharmaceutical company BioNTech says it plans to create a state-of-the-art manufacturing site for its mRNA-based vaccines and other drugs in Singapore. The company, which developed the first widely used coronavirus vaccine together with U.S. partner Pfizer, said Monday that it is also establishing a regional headquarters for Southeast Asia in the city-state. …
The Latest: BioNTech to make vaccines in Singapore Read More »